Equity and Accessibility of MDMA-Assisted Therapy
Psychedelic medicine continues to move forward, but minority communities are being left behind.
Mental Health - Page 8
Methoxetamine: Cousin of Ketamine
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
It Takes Guts: Psychedelic Treatment Approaches to Autoimmune Disorders
There is much research into psychedelic treatment of mental disorders, but psychedelics might be effective in treating autoimmune disorders as well.
The Top 10 Psychedelic Research Papers of 2020
Psychedelic-assisted psychotherapy leads the way in 2020’s top psychedelic papers.
How to Change Your Ability to Change
The monoamine hypothesis of depression leaves many patients without effective help. It’s time for a paradigm shift, and psychedelics may be leading the way.
Pilot Study of Psilocybin-Assisted Group Therapy in Older AIDS Survivors
Feasibility, safety, and potential efficacy of psilocybin-assisted group therapy was demonstrated in treating demoralization in this marginalized population.
ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration
Harnessing the theoretical and technical synergy between Acceptance and Commitment Therapy (ACT) and Psychedelic Assisted Psychotherapy (PcbAP)
The Ayahuasca Afterglow Phenomenon: Exploring Its Significance and Limitations
The afterglow effect is commonly referenced in psychedelic literature. However, limited attention is being paid to several uncontrolled variables.
Ketamine Helps People Dislike Themselves Less
New research shows that ketamine reduces self-dislike, loosening the rigid prejudice toward oneself that can constitute depression.
Examining the Effects of Psychedelics on Experiential Avoidance
Experiential avoidance is one transdiagnostic process that may be implicated in the therapeutic benefits of psychedelics.